← Back to Search

Behavioural Intervention

Acupressure Arm 1 for Postmenopausal

N/A
Recruiting
Led By Norah Henry
Research Sponsored by University of Michigan Rogel Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 12 weeks after intervention is started
Awards & highlights

Study Summary

This trial is testing whether self-acupressure can help relieve joint pain and stiffness in postmenopausal women with breast cancer who are taking aromatase inhibitors. Acupressure is a

Who is the study for?
This trial is for postmenopausal women and men over 18 with breast cancer who've completed surgery and possibly chemotherapy. They must be experiencing new or worsening joint pain from aromatase inhibitor therapy, have stable internet access, and agree to use the same AI therapy for at least 12 weeks. Exclusions include recent acupressure/acupuncture users, estrogen users during the study, those planning surgeries within the study period, or having concurrent conditions that could affect pain assessment.Check my eligibility
What is being tested?
The trial tests self-acupressure's effectiveness on musculoskeletal symptoms caused by aromatase inhibitors in breast cancer patients. It's a randomized, double-blinded study where participants apply pressure to specific body points themselves to relieve joint pain and stiffness. The impact on other symptoms and changes in gut microbiome due to acupressure are also being explored.See study design
What are the potential side effects?
Acupressure is generally considered safe but may cause minor side effects like soreness at pressure points, bruising, or fatigue. Since it's non-invasive unlike acupuncture which uses needles, risks of serious side effects are low.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks after intervention is started
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks after intervention is started for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in joint pain
Secondary outcome measures
Adherence to trial intervention (number of days completed)
Adherence to trial intervention (number of minutes completed)
Change in anxiety
+9 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Acupressure Arm 2Experimental Treatment1 Intervention
There are 5 acupoints with 4 of the acupoints performed on both the left and right sides of the body. Each of the 9 acupoints will be stimulated for 3 minutes per point giving a total treatment time of 27 minutes daily. The acupoints are unlisted in order to maintain blinding.
Group II: Acupressure Arm 1Experimental Treatment1 Intervention
There are 5 acupoints with 4 of the acupoints performed on both the left and right sides of the body. Each of the 9 acupoints will be stimulated for 3 minutes per point with the AcuWand giving a total treatment time of 27 minutes daily. The relaxation acupoints are unlisted in order to maintain blinding.

Find a Location

Who is running the clinical trial?

Breast Cancer Research FoundationOTHER
69 Previous Clinical Trials
137,717 Total Patients Enrolled
1 Trials studying Postmenopausal
71 Patients Enrolled for Postmenopausal
University of Michigan Rogel Cancer CenterLead Sponsor
294 Previous Clinical Trials
24,211 Total Patients Enrolled
Norah HenryPrincipal InvestigatorUniversity of Michigan Rogel Cancer Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the cap on participant enrollment for this study?

"Yes, as per clinicaltrials.gov information, this trial is currently open for enrollment. The initial posting of the trial was on March 1st, 2024, with the most recent update made on March 4th, 2024. A total of 50 participants are sought from a single site."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Acupressure for Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Patients With Breast Cancer
2024. "Acupressure for Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Patients With Breast Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06228768.
All > Aromatase Inhibitor
~33 spots leftby May 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top